Skip to content

BNTCBENITEC BIOPHARMA INC

CUSIP 08205P209 · common stock

1 tracked investor held BENITEC BIOPHARMA INC (BNTC) at the end of Q3 2026, worth $18.5M. The largest holder was RA Capital Management, with 0.2% of its portfolio. Adar1 Capital Management sold out of its position this quarter.

Holders · Q3 2026
1
New holders
0
Value held
$18.5M
Quarter-end price (est.)
$10.00

Investors holding BNTC · Q3 2026

InvestorWeightSharesValueChange
RA Capital Management
RA Capital Management, L.P.
0.19%1,850,000$18.5MHOLD

Sold out this quarter

InvestorPrior weightPrior sharesPrior valueChange
Adar1 Capital Management0.02%40,000$535.2KEXIT

History

QuarterHoldersNewSold outValue heldQuarter-end price (est.)
Q3 2026101$18.5M$10.00
Q2 2026200$25.3M$13.38
Q1 2026210$19.9M$10.65
Q4 2025100$24.9M$13.47